Riskpilot← Back to searchSign inGet full accessSARRAJ MEDICAL AB
ABActiveOrg 5569111189Bellmansgatan 26General medical practice activities · NACE 8621Est. 20120 employees
Revenue 2024
SEK 0
EBITDA margin
—
+98% vs 2023
Equity ratio
18.8%
Financial strength
Net profit 2024
SEK -14K
+88% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -3K | +98% |
| Net profit | SEK -14K | +88% |
| Total assets | SEK 186K | -10% |
| Equity | SEK 35K | -28% |
| Employees | 0 | — |
Legal name
SARRAJ MEDICAL AB
Org number
5569111189
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
20 november 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva rekrytering och konsultation inom hälso- och sjukvård, handel med värdepapper samt därmed förenlig verksamhet.
Address
Bellmansgatan 26
Email
sherzii65@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 546 | 209 | 1 156 | 5 | 0 |
| Staff expenses | — | — | 382 | −69 | −0 |
| EBITDA | 272 | −200 | 1 241 | −135 | −3 |
| Depreciation & amort. | −47 | −47 | −20 | — | — |
| EBIT | 225 | −247 | 1 222 | −135 | −3 |
| Net financials | −6 | −3 | −12 | 25 | −10 |
| Profit before tax | 161 | −37 | 1 209 | −110 | −14 |
| Tax | −38 | −0 | −251 | — | — |
| Net profit | 123 | −37 | 958 | −110 | −14 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 663 | 2 074 | 1 519 | 208 | 186 |
| Equity | 1 949 | 1 684 | 1 009 | 49 | 35 |
| Long-term debt | 0 | 0 | 57 | −280 | −78 |
| Short-term debt | 501 | 390 | 452 | 439 | 229 |
| Total debt | 501 | 390 | 510 | 159 | 151 |
EBITDA margin
-320900.0%
This company
15.8%
Market median
-2031113% vs market
20202024
Equity ratio
18.8%
This company
38.2%
Market median
-51% vs market
20202024
Return on equity
-39.0%
This company
18.4%
Market median
-312% vs market
20202024
Net profit margin
-1370600.0%
This company
8.1%
Market median
-16921088% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
4.31×
This company
0.62×
Market median
-595% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SZ Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SARRAJ MEDICAL AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sherwan Zindrou | Chief Executive Officer | 0 companies |
| Sengin Lézan Zindrou | Deputy Board Member | 0 companies |